Primary Immunodeficiency Diseases Worldwide: More Common than Generally Thought
- 2.5k Downloads
Primary immunodeficiency diseases (PIDs) comprise at least 176 hereditary disorders that are thought to be individually and collectively rare. The actual prevalence and incidence of PIDs remains unclear, but recent epidemiologic studies have suggested that PIDs are more common than generally thought. Based on these studies, we attempted to estimate the worldwide prevalence and incidence of PIDs.
Using data from registries and two recent epidemiologic surveys estimating the frequencies of PIDs, we extrapolated the frequencies reported for certain countries to the populations of continents and of the world.
Our upper estimates suggest that six million people may be living with a PID worldwide, whereas only 27,000–60,000 have been identified to date (all national registries and the Jeffrey Modell Centers Network, respectively). For Europe, our upper estimate was 638,000 cases, and 15,052 cases are currently registered (2.27 %). In Africa, up to 902,631 people may have a PID, whereas only 1,016 cases are currently registered. We also found that PIDs were prevalent not only in children, but also in adults, who were strongly underrepresented in registries.
Specific, dedicated epidemiologic studies are required, to obtain more realistic statistics for PIDs and to increase the awareness of physicians and public health systems about these diseases. Furthermore, the field of PIDs is continually growing, and this is likely to lead to a revision of the definition of these conditions, potentially increasing estimates of their impact on both adults and children, at the population level.
KeywordsPrimary immunodeficiency prevalence incidence mortality
Conflict of Interest
The authors declare that they have no conflict of interest.
- 1.Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front Immunol. 2011;2:54. doi: 10.3389/fimmu.2011.00054.PubMedGoogle Scholar
- 16.Boisson-Dupuis S, El Baghdadi J, Parvaneh N, Bousfiha A, Bustamante J, Feinberg J, et al. IL-12Rβ1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey. PLoS One. 6(4):e18524.Google Scholar
- 18.Rare diseases. In: Health-EU: The Public Health Portal of European Union. 2011. http://ec.europa.eu/health-eu/health_problems/rare_diseases/index_en.htm. Accessed 11 Sept 2011.
- 19.ESID database statistics. In: European Society for Immunodeficiencies. 2011. http://www.esid.org/statistics.php. Accessed 26 Jan 2012.
- 25.Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol. 2006;26(6):519–32.PubMedCrossRefGoogle Scholar
- 27.Total number of patients in the USIDnet registry. In: US Immunodeficiency Network. 2004. http://www.usidnet.org/index.cfm. Accessed 6 Feb 2012.
- 28.African Society for Immunodeficiencies ASID. 2009. http://www.asid.ma. Accessed 11 Sept 2011.
- 31.World Population Prospects: The 2010 Revision. In: United Nations, Department of Economic and Social Affairs, Population Division. 2011. http://esa.un.org/unpd/wpp/Excel-Data/population.htm. Accessed 23 May 2011.
- 32.SEER Stat Fact Sheets: Leukemia. In: Surveillance, Epidemiology, and End Results Program. 2010. http://seer.cancer.gov/statfacts/html/leuks.html. Accessed 1 Aug 2011.
- 33.Tadmouri GO, Nair P, Obeid T, Al Ali MT, Al Khaja N, Hamamy HA. Consanguinity and reproductive health among Arabs. Reprod Health. 2009. doi: 10.1186/1742-4755-6-17.
- 34.Naamane H, El Maataoui O, Ailal F, Barakat A, Bennani S, Najib J, et al. The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population. Eur J Pediatr. 2010;169(9):1069–74.PubMedCrossRefGoogle Scholar
- 36.Ben Mustapha I, Kammoun A, Mellouli F, Abdelmoula MS, Chemli J, Largueche B, et al. A strong founder effect for a 10-bp deletion in the CD18 gene in North African leukocyte adhesion deficiency type I patients. Clin Exp Immunol. 2008;154:105.Google Scholar
- 37.Sanchez JJ, Monaghan G, Børsting C, Norbury G, Morling N, Gaspar HB. Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestry. Ann Hum Genet. 2006;71:336–47.CrossRefGoogle Scholar